A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
Trial details
- Registry ID
- NCT07584226
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid TumorsNCT07584226 | RLAY | Phase 1, Phase 2 | Recruiting | 2029-05-31Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |